ADAR1 Capital Management »

Actinium Pharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Actinium Pharmaceuticals (ATNM) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Actinium Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Actinium Pharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actinium Pharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $783k 100k 7.83

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Actinium Pharmaceuticals

BlackRock
Vanguard Group
Geode Capital Management
Verition Fund Management
Susquehanna International
Northern Trust
Citadel Advisors
Marshall Wace
Brandywine Global Investment Management
Dimensional Fund Advisors
ADAR1 Capital Management
Nuveen Asset Management
Hudson Bay Capital Management
Bridgeway Capital Management
Virtu Financial

View all funds holding Actinium Pharmaceuticals